Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA.

Am J Hum Genet. 2005 Oct;77(4):617-26. Epub 2005 Sep 1.

2.

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Németh E, Nielsen EW, Nuijens JH, O'grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Späth PJ, Szendei G, Takács E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L.

J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131.

PMID:
15356535
3.

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.

Cicardi M, Zingale LC, Bergamaschini L, Agostoni A.

Arch Intern Med. 2004 Apr 26;164(8):910-3.

PMID:
15111379
4.

Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.

Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A.

Medicine (Baltimore). 2003 Jul;82(4):274-81. Review.

5.

Bradykinin and the pathophysiology of angioedema.

Cugno M, Nussberger J, Cicardi M, Agostoni A.

Int Immunopharmacol. 2003 Mar;3(3):311-7. Review.

PMID:
12639808
6.

[Vasopeptidases and their inhibitors].

Agostoni A.

Recenti Prog Med. 2002 Oct;93(10):519-22. Review. Italian.

PMID:
12405010
7.

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.

Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A.

J Pharmacol Exp Ther. 2002 Oct;303(1):232-7.

8.

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors.

Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A.

Lancet. 2002 Jun 15;359(9323):2088-9.

PMID:
12086766
9.

[The kinin system: biological mechanisms and clinical implications].

Agostoni A, Cugno M.

Recenti Prog Med. 2001 Dec;92(12):764-73. Review. Italian.

PMID:
11822101
10.

Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.

Cugno M, Nussberger J, Biglioli P, Alamanni F, Coppola R, Agostoni A.

Chest. 2001 Dec;120(6):1776-82.

PMID:
11742901
11.

Bradykinin in the ascitic fluid of patients with liver cirrhosis.

Cugno M, Salerno F, Nussberger J, Bottasso B, Lorenzano E, Agostoni A.

Clin Sci (Lond). 2001 Dec;101(6):651-7.

PMID:
11724653
12.

Drug-induced angioedema without urticaria.

Agostoni A, Cicardi M.

Drug Saf. 2001;24(8):599-606. Review.

PMID:
11480492
13.

In vitro interaction of C1-inhibitor with thrombin.

Cugno M, Bos I, Lubbers Y, Hack CE, Agostoni A.

Blood Coagul Fibrinolysis. 2001 Jun;12(4):253-60.

PMID:
11460008
14.

Influence of contact system deficiencies during cardiopulmonary bypass.

Agostoni A, Cugno M.

Thromb Haemost. 2001 Feb;85(2):191-2. No abstract available. Erratum in: Thromb Haemost 2001 Mar;85(3):576. Agostini A [corrected to Agostoni A].

PMID:
11246529
15.

The region 1-11 of Alzheimer amyloid-beta is critical for activation of contact-kinin system.

Bergamaschini L, Donarini C, Foddi C, Gobbo G, Parnetti L, Agostoni A.

Neurobiol Aging. 2001 Jan-Feb;22(1):63-9.

PMID:
11164277
16.

[The ethical dilemma of placebos].

Agostoni A.

Recenti Prog Med. 2000 Nov;91(11):549-51. Italian. No abstract available.

PMID:
11125945
17.

Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema.

Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, Tosi M.

J Allergy Clin Immunol. 2000 Dec;106(6):1147-54.

PMID:
11112899
18.

Acquired C1 esterase inhibitor deficiency.

Cicardi M, Agostoni A, Davis AE.

Ann Intern Med. 2000 Nov 21;133(10):837-8; author reply 839. No abstract available.

PMID:
11085852
19.

Plasma bradykinin levels in human chronic congestive heart failure.

Cugno M, Agostoni P, Brunner HR, Gardinali M, Agostoni A, Nussberger J.

Clin Sci (Lond). 2000 Nov;99(5):461-6.

PMID:
11052927
20.

Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.

Cugno M, Dominguez M, Cabibbe M, Bisiani G, Galli M, Angles-Cano E, Agostoni A.

Br J Haematol. 2000 Mar;108(4):871-5.

PMID:
10792298
21.

Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C.

Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E, Agostoni A, Colombo M.

J Viral Hepat. 2000 Mar;7(2):138-43.

PMID:
10760044
22.

Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits.

Gardinali M, Borrelli E, Chiara O, Lundberg C, Padalino P, Conciato L, Cafaro C, Lazzi S, Luzi P, Giomarelli PP, Agostoni A.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1022-9.

PMID:
10712358
23.

Angioedema due to angiotensin-converting enzyme inhibitors.

Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J.

Immunopharmacology. 1999 Oct 15;44(1-2):21-5.

PMID:
10604520
24.

Cardiopulmonary bypass increases plasma bradykinin concentrations.

Cugno M, Nussberger J, Biglioli P, Giovagnoni MG, Gardinali M, Agostoni A.

Immunopharmacology. 1999 Sep;43(2-3):145-7.

PMID:
10596846
25.

Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.

Cugno M, Scott CF, Salerno F, Lorenzano E, Müller-Esterl W, Agostoni A, Colman RW.

Thromb Haemost. 1999 Nov;82(5):1428-32.

PMID:
10595632
26.

Local bradykinin generation in hereditary angioedema.

Nussberger J, Cugno M, Cicardi M, Agostoni A.

J Allergy Clin Immunol. 1999 Dec;104(6):1321-2. No abstract available.

PMID:
10589018
27.

Idiopathic nonhistaminergic angioedema.

Cicardi M, Bergamaschini L, Zingale LC, Gioffré D, Agostoni A.

Am J Med. 1999 Jun;106(6):650-4.

PMID:
10378623
28.

Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway.

Bergamaschini L, Miedico A, Cicardi M, Coppola R, Faioni EN, Agostoni A.

Clin Exp Immunol. 1999 May;116(2):220-4.

29.

Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.

Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, Agostoni A.

Clin Exp Immunol. 1999 Mar;115(3):526-33.

30.

C1 inhibitor function and anti-C1 inhibitor autoantibodies in patients with HIV type 1 infection.

Beretta A, Zanichelli A, Agostoni A, Cicardi M, Gringeri A.

AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):95-6. No abstract available.

PMID:
10024060
31.

Pathogenetic and clinical aspects of C1 inhibitor deficiency.

Cicardi M, Bergamaschini L, Cugno M, Beretta A, Zingale LC, Colombo M, Agostoni A.

Immunobiology. 1998 Aug;199(2):366-76. Review.

PMID:
9777420
32.

Plasma bradykinin in angio-oedema.

Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A.

Lancet. 1998 Jun 6;351(9117):1693-7.

PMID:
9734886
33.

Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease.

Bergamaschini L, Parnetti L, Pareyson D, Canziani S, Cugno M, Agostoni A.

Alzheimer Dis Assoc Disord. 1998 Jun;12(2):102-8.

PMID:
9651139
34.

Complement system is not activated in primary biliary cirrhosis.

Gardinali M, Conciato L, Cafaro C, Crosignani A, Battezzati PM, Agostoni A, Podda M.

Clin Immunol Immunopathol. 1998 Jun;87(3):297-303.

PMID:
9646840
35.

Effects of radiographic contrast media.

Gardinali M, Cicardi M, Agostoni A.

Invest Radiol. 1997 Oct;32(10):648-9. No abstract available.

PMID:
9342126
36.

Activation of the coagulation cascade in C1-inhibitor deficiencies.

Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A.

Blood. 1997 May 1;89(9):3213-8.

37.

Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.

Castelli R, Cicardi M, Gardinali M, Zingale LC, Savi C, Munari M, Agostoni A.

Int J Artif Organs. 1997 Mar;20(3):175-7.

PMID:
9151154
38.

Idiopathic capillary leak syndrome: evidence of CD8-positive lymphocytes surrounding damaged endothelial cells.

Cicardi M, Berti E, Caputo V, Radice F, Gardinali M, Agostoni A.

J Allergy Clin Immunol. 1997 Mar;99(3):417-9. No abstract available.

PMID:
9058699
39.

Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients.

Cicardi M, Castelli R, Zingale LC, Agostoni A.

J Allergy Clin Immunol. 1997 Feb;99(2):194-6. No abstract available.

PMID:
9042044
40.

Angioedema due to angiotensin-converting enzyme inhibition: an association frequently unrecognized.

Cicardi M, Conciato L, Agostoni A.

Ann Ital Med Int. 1997 Jan-Mar;12(1):8-10.

PMID:
9284593
41.

Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema.

Cicardi M, Beretta A, Colombo M, Gioffré D, Cugno M, Agostoni A.

Clin Exp Immunol. 1996 Dec;106(3):475-80.

42.

Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.

Cugno M, Cicardi M, Colucci M, Bisiani G, Merlini PA, Spinola A, Paonessa R, Agostoni A.

Thromb Haemost. 1996 Aug;76(2):234-8.

PMID:
8865537
43.

Hereditary angioedema.

Cicardi M, Agostoni A.

N Engl J Med. 1996 Jun 20;334(25):1666-7. No abstract available.

PMID:
8628365
44.
45.

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.

Bergamaschini L, Santangelo T, Faricciotti A, Ciavarella N, Mannucci PM, Agostoni A.

J Immunol. 1996 Feb 1;156(3):1256-61.

PMID:
8558005
46.

Placebo and EU guidelines.

Agostoni A.

Lancet. 1995 Dec 23-30;346(8991-8992):1710. No abstract available.

PMID:
8551856
47.

[Side effects of thrombolytic therapy in patients with myocardial infarction].

Agostoni A, Gardinali M.

Cardiologia. 1995 Dec;40(12):899-908. Review. Italian. No abstract available.

PMID:
8901040
48.

Cardioprotective effect of C1-inhibitor.

Cicardi M, Cugno M, Agostoni A.

Circulation. 1995 Nov 1;92(9):2758-9. No abstract available.

PMID:
7586384
49.

Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy.

Testoni PA, Cicardi M, Bergamaschini L, Guzzoni S, Cugno M, Buizza M, Bagnolo F, Agostoni A.

Gastrointest Endosc. 1995 Oct;42(4):301-5.

PMID:
8536896
50.

Complement system in coronary heart disease: a review.

Gardinali M, Conciato L, Cafaro C, Agostoni A.

Immunopharmacology. 1995 Aug;30(2):105-17. Review. No abstract available.

PMID:
8530252

Supplemental Content

Loading ...
Support Center